Analysis of gene expression in intracranial aneurysms
Chinese Neurosurgical Journal volume 3, Article number: 34 (2017)
Different gene expression profiles are observed in intracranial aneurysm tissue. Understanding these genes and what regulates their expression will help us to understand intracranial aneurysm pathogenesis. We investigated whether differences in gene expression in intracranial aneurysms.
Sixteen intracranial aneurysm tissues were compared with 16 matched samples from the superficial temporal artery as controls. We detected the gene expression profiles in these samples with the Human U133 Plus 2.0 GeneChip.
A total of 2142 differentially expressed gene transcripts were detected based on the gene expression profile. Verification analysis showed that the VCAM1, MAGI2, PPP2R2B, PPP2R3A genes were associated with the occurrence and development of intracranial aneurysm. These genes mainly encode cell adhesion molecules (CAMs) and ERK/JNK signaling pathways.
Changes of genes expression involved in immune and inflammatory reactions, cell adhesion molecules may be associated with the development of aneurysms.
Intracranial aneurysmal subarachnoid hemorrhage is associated with high mortality and morbidity . The risk factors for intracranial aneurysms include smoking, drinking, aging, female gender, hypertension, drug abuse, and use of medicinethat can lead to arteriosclerosis and hypertension . However, genetic factors remainthe most important indicator for the occurrence, development, and rupture of intracranial aneurysms. Genetic factors can lead to changes in hemodynamics, artery structure, inflammation, and autoimmune function, which are linked to the onset of intracranial aneurysms [3,4,5,6]. Moreover, many single nucleotide polymorphisms (SNPs) were identified as participating in the formation, development, and rupture of sporadic intracranial aneurysms [7,8,9]. However, due to regional and ethnic differences, identification of the pathogenic genes in aneurysms is difficult. Therefore, understanding gene expression and their regulating factors in intracranial aneurysms remains crucial for understanding its pathogenesis.
This study selected the tissue of intracranial aneurysm and superficial temporal artery of the same patients as control group to discuss the mechanism of intracranial aneurysm in gene expression.
Materials and methods
A total of 16 patients with intracranial aneurysms, who underwent intracranial aneurysm clip resection at the Beijing Tiantan Hospital, were selected from December 2013 to December 2015. The inclusion criteria were: (1) age ≥ 18 years, (2) Han nationality, and (3) a diagnosis of intracranial aneurysms by whole cerebral digital subtraction angiography (DSA). Tissue from the wall of the intracranial aneurysm (experimental group) and tissue from the superficial temporal artery (control group) were dissected during the intracranial aneurysm clip resection surgery for each patient. To avoid RNA degradation, the blood on the surface of tissue was quickly removed after dissection, and the tissue was immersed in RNAlater (Qiagen, Valencia, CA) solution and frozen at -80C.
All experiments in this study were reviewed and approved in advance by the Ethics Committee of the Beijing Tiantan Hospital, Capital Medical University. All participants provided their written consent to participate in this study.
Gene expression profiles
Total RNA was extracted and purified by RNeasy micro kit (Cat#74004, Qiagen, GmBH, Germany) following manufacturer’s instructions and checked with an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, US) for RNA integrity. RNA samples from each group were then used to generate biotinylated cRNA targets for the Human Genome U133 Plus2.0 Gene Chip microarrays (Affymetrix, Santa Clara, CA) the biotinylated cRNA targets were then hybridized with the microarray. After hybridization, arrays were stained in a Fluidics Station 450, and scanned on an Affymetrix Scanner3000. The microarray experiments were performed following the protocol of Affymetrix Inc. at Shanghai Biotechnology Corporation. The raw data were normalized byGenespring software (Agilent). Genes with a fold change (FC) ≥ 2, and a P ≤ 0.05 difference between the intracranial aneurysm tissue and the matched superficial temporal artery tissue (n = 16) were selected for further analysis. The selected genes were grouped in functional categories based on the Gene Ontology database (GO: http://www.geneontology.org/), and functional pathways (KEGG and BIOCARTA) were analyzed by the online SAS analysis system (http://sas.ebioservice.com/portal/root/molnet_shbh/index.jsp).
Quantitative real-time PCR analysis
Reverse transcription was performed with iScript cDNA synthesis kit (BIO-RAD, USA). The housekeeping gene Actin was used as an endogenous control to normalize the expression level of target genes. qPCR was performed in 7900 HT Sequence Detection System (ABI, USA) by ABI Power SYBR Green PCR Master Mix (ABI, USA).
Patients’ clinical information
We collected 16 intracranial aneurysm tissues and 16 matched samples from the superficial temporal artery including 9 unruptured aneurysms and 7 ruptured aneurysms, in which, 6 cases were male; 10 cases were female and the male to female ratio was 1:1.67. The patients aged from 6 to 69 years, with an average of 48.72 ± 7.35 years, in which male patients aged in average 42.39 ± 10.21 years and male in average 54.91 ± 3.97 years. One aneurysm located in right anterior communicating artery (ACoA); three aneurysms located in left internal carotid artery (ICA) and two in right ICA; four aneurysms located in left middle cerebral artery (MCA) and three in right MCA; two aneurysms located in left posterior communicating artery (PCoA) and one in right PCoA.
Differentiated genes analysis
In total, 2142 differentially expressed genes (DEGs) (i.e., FC ≥ 2 and P ≤ 0.05) were identified. Of these, 1203 genes were up-regulated and 939 were down-regulated in intracranial aneurysms compared to matched controls.
Volcano plot was drawn through p-value and Fold change obtained from T test of single fluorescent chip to show the significant difference between two groups (Fig. 1).
The principle of PCA (Principal Component Analysis) was to find two principal components (vector) whose variance was the largest. Data were projected on principal components to reduce the dimension. The similarity of samples was showed through the distance between the points on the image, which also investigated the distribution of samples and validated the rationality of experimental design (Fig. 2).
Cluster analysis of gene expression was made to comprehensively and intuitively show the relationship and difference between samples. The expression of differentiated genes was calculated the correlation of samples. In general, the same samples appeared in one cluster through the clustering. Genes in one cluster may have similar biological functions.Cluster 3.0 analyzed all the transcript data in cluster (Fig. 3).
Gene expression profile was screened and analyzed by SAM (significance analysis of microarray) and got 3736 transcript of differentiated expression (Fold-change ≥ 2, FDR < 0.01), 179 of which had more than 10 times expression differences (FDR < 0.01). The maximum amplitude of up-regulation was 88.092 and the maximum amplitude of down-regulation was 59.880 in all transcripts with different expression. The function of differences gene between intracranial aneurysm and superficial temporal artery were immune and inflammatory reaction, cell function and maintain, cell signal transduction and the interaction.
Validation of expression profile
We confirmed a significant difference (paired t test, P < 0.05) in the mRNA levels between aneurysm and control samples by qRT-PCR. From the 6 genes of 16 paired samples, 4 of them (VCAM1, MAGI2, PPP2R2B, PPP2R3A) were significantly different (p = 0.030, p = 0.010, p = 0.001, p = 0.000) by paired T test (Table 1).
In recent years, more and more high throughput methods were used to screen the pathogenic gene of intracranial aneurysm . Lots of studies on whole genome sequencing of single nucleotide polymorphism (SNP) demonstrated different single nucleotide polymorphism loci may participate in the formation, development and rupture of intracranial aneurysms. Due to regional and ethnic differences, it was difficult to get the exact pathogenic gene.
Research on the gene expression profile of intracranial aneurysm showed there was difference in genes of inflammatory reaction, cell adhesion and anti-adhesion, cytokinesis and cell migration. The abnormality in the regulation of gene expression caused by environmental factors was the important factor which led to the difference in gene expression. This study aimed to explore the expression of important genes during the occurrence and development of intracranial aneurysm. In intracranial aneurysm and superficial temporal artery tissue of the same person, genome was the same while there was difference in gene expression profile. The occurrence of intracranial aneurysm was influenced by environmental factors and had different degrees of the genes expression. Differences in gene expression of intracranial aneurysm may cause the occurrence of intracranial aneurysm through cell adhesion molecules (CAMs), ERK and JNK signal transduction pathways.
Cell adhesion molecules (CAM) and MAGI2 gene
In the process of inflammation, the stability of cell membrane decreased and the permeability increased. Tight junctions were the important factors to maintain the integrity of blood-brain barrier (BBB). Membrane-associated guanylic acid kinase (MAGI2) gene encoding protein interacted with atrophin-1 (ATN1) gene encoding protein, which belonged to membrane-associated guanylate kinase homologue (MAGUK) family which had the similar structure. MAGI2 mainly recruit specific cellular signaling proteins to format polymer complex through cell membrane, which played a role of cell signal transduction and steady cell membrane structure. Studies showed that MAGI2 protein signal transduction pathway could inhabit the migration and proliferation of tumor cells, which was related to phosphorylation of FAK and Akt . The expression profile of MAGI2 gene in brain aneurysms was decreased. The stability of member declined, which made it easy to vascular remodeling and aneurysms formation.
ERK and JNK signal transduction pathway and PPP2R2B gene
Mitogen activated protein kinase (MAPK) signaling pathway played an important role in the process of messages transferred from extracellular to intracellular. There were mainly four MAPK signal transduction pathways, extracellular regulated protein kinase (ERK) transduction pathway, c-JunN-terminal kinase (JHK)/stress activated protein kinase transduction pathway, ERKS/large mitogen activated protein kinase transduction pathway and p38 mitogen activated protein kinases (p38MAPK) transduction pathways. ERK and JNK were the important members of the MAPK family, both of which could reply to various extracellular stimuli, such as growth factors, tumor necrosis factor and emergency stimulus and involve in the mediation of cell proliferation, movement and death and DNA damage repair.
The product of PPP2R2B gene was regular subunit of PP2A . Researches showed that PP2A was negative to the regulation of ERK and JNK signal transduction pathway. The dysfunction of PP2A was related to the phosphorylation of Tau . PP2A played an important role in cell cycle regulation, tau phosphorylation, inflammation and apoptosis . The expression profile of PPP2R2B gene decreased in brain aneurysm samples, which participated in the inflammation of vessel wall and was associated with the development of aneurysm.
This study detected the expression profile of genome-wide and found there was significant difference between intracranial aneurysm and superficial temporal artery in the gene expression profile of immune and inflammatory reaction, cell function and maintain, cell signal transduction and the interaction. VCAM1, MAGI2, PPP2R2B, PPP2R3A gene mainly involved in the signal transduction pathways of cell adhesion molecules, ERK and JNK signal transduction pathways, which played an important role in the occurrence and development of aneurysms. The analysis of genes related to the formation of intracranial aneurysm and screen of molecular markers by gene chip and bioinformatics provided new ideas for studies of the mechanism, diagnosis, treatment of aneurysm.
The limitations of the study were as follow. First of all, the specimen was intracranial aneurysms, which was on the terminal stage of pathological changes. The difference in gene expression profile could not fully reflect the early condition of aneurysm, so it could not fully reflect the pathophysiological process of intracranial aneurysm. Secondly, there may be difference in gene expression profile between unruptured intracranial aneurysms and ruptured aneurysms. Due to the sample size, this experiment didn’t analyze the ruptured intracranial aneurysms and unruptured intracranial aneurysms.
Anterior carotid artery
Anterior communicating artery
Cell adhesion molecules
Differentially expressed genes
Digital subtraction angiography
Extracellular regulated protein kinase
Internal carotid artery
Membrane associated guanylate kinase 2
Membrane-associated guanylate kinase
Mitogen activated protein kinase
Middle cerebral artery
Principal component analysis
Posterior communicating artery
Protein phosphatase 2, regulatory subunit B, beta
Protein phosphatase 2, regulatory subunit B, alfa
Significance analysis of microarray
Serum glucocorticoid regulated kinase 3
Single nucleotide polymorphisms
Vascular cell adhesion molecule 1
Peters DG, Kassam AB, Feingold E, Heidrich-O'Hare E, Yonas H, Ferrell RE, Brufsky A. Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke. 2001;32(4):1036–42.
Clarke M. Systematic review of reviews of risk factors for intracranial aneurysms. Neuroradiology. 2008;50(8):653–64.
Ruigrok YM1, Wijmenga C, Rinkel GJ, van't Slot R, Baas F, Wolfs M, Westerveld A, Roos YB. Genomewide linkage in a large Dutch family with intracranial aneurysms: replication of 2 loci for intracranial aneurysms to chromosome 1p36.11-p36.13 and Xp22.2-p22.32. Stroke. 2008;39(4):1096–102.
Nahed BV1, Seker A, Guclu B, Ozturk AK, Finberg K, Hawkins AA, ML DL, State M, Lifton RP, Gunel M. Mapping a Mendelian form of intracranial aneurysm to 1p34.3-p36.13. Am J Hum Genet. 2005;76(1):172–9.
Roos YB, Pals G, Struycken PM, Rinkel GJ, Limburg M, Pronk JC, van den Berg JS, Luijten JA, Pearson PL, Vermeulen M, Westerveld A. Genome-wide linkage in a large Dutch consanguineous family maps a locus for intracranial aneurysms to chromosome 2p13. Stroke. 2004;35(10):2276–81.
Santiago-Sim T, Depalma SR, KL J, McDonough B, Seidman CE, Seidman JG, Kim DH. Genomewide linkage in a large Caucasian family maps a new locus for intracranial aneurysms to chromosome 13q. Stroke. 2009;40(3 Suppl):S57–60.
Osman W, Low SK, Takahashi A, Kubo M, Nakamura YA. genome-wide association study in the Japanese population confirms 9p21 and 14q23 as susceptibility loci for primary open angle glaucoma. Hum Mol Genet. 2012;21(12):2836–42.
Alg VS, Sofat R, Houlden H, Werring DJ. Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology. 2013;80(23):2154–65.
Bilguvar K, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet. 2008;40:1472–7.
Li L, Yang X, Jiang F, Dusting GJ, et al. Transcriptome-wide characterization of gene expression associated with unruptured intracranial aneurysms. Eur Neurol. 2009;62:330–7.
Hu Y, Li Z, Guo L, et al. MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells. Archives of Biochemistry. Biophysics. 2007;467(1):1–9.
Holmes SE, O'Hearn EE, Mcinnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5|[prime]| regionof PPP2R2B is associated with SCA12. Nat Genet. 1999;23(4):391–2.
Kins S, Kurosinski P, Jü RMNA, et al. Activation of the ERK and JNK Signaling Pathways Caused by Neuron-Specific Inhibition of PP2A in Transgenic Mice. Am J Pathol. 2003;163(3):833–43.
RK DA. developmentally regulated, neuron-specific splice variant of the variable subunit Bbeta targets protein phosphatase 2A to mitochondria and modulates apoptosis. J Biol Chem. 2003;278(27):24976–85.
We thank all the participants for their support of this research.
National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2015BAI12B04).
This work was supported by “Research on the genetics and pathogenesis of intracranial aneurysm and arteriovenous malformation”, acooperative project of The Science and Technology Ministry of China and Canada by JizongZhao (No. 2010dfb30850) and National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2015BAI12B04).
Availability of data and materials
All data generated or analysed during this study are included in this published article.
Ethics approval and consent to participate
The author daclare that all procedures in this study involving human participants were in accordance with the ethical standards of our institutional with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All experiments in this study were reviewed and approved in advance by the Ethics Committee of the Beijing Tiantan Hospital, Capital Medical University. (KY2011–002-02).
Consent for publication
The authors declare that they have no competing interests.
About this article
Cite this article
Wang, J., Yu, L., Zhang, D. et al. Analysis of gene expression in intracranial aneurysms. Chin Neurosurg Jl 3, 34 (2017). https://doi.org/10.1186/s41016-017-0098-z